Poll: Is the New Prenatal Blood Test for Trisomy 21 a Good Thing?
A new prenatal blood test for trisomy 21 has been released in Europe, and it's targeted to women in their 12th week and beyond. Is it a good thing?
A new prenatal blood test for trisomy 21 has been developed for women in their 12th week and beyond who are at increased risk for carrying a fetus with Down Syndrome. The test, which is at least 95% accurate, has already been released in Europe by the German company LifeCodexx under the name PrenaTest. An international federation of Down Syndrome organizations appealed to the European Court of Human Rights to stop the release of the test, and some physicians and advocates are concerned that the test will lead to an increase of abortions.
The makers of the test encourage amniocentesis ad genetic counseling for any woman with a positive test result. Amniocentesis, which has been the primary method of detection for trisomy 21, has a 1% risk of fetal loss in the 16th week.
Online Poll
|
Online Survey
Single iron infusion in late pregnancy significantly reduces anemia risk
January 22nd 2025A recent study found that a single dose of intravenous iron in the third trimester is superior to oral iron in reducing anemia rates in pregnant women, ensuring better outcomes for mother and baby.
Read More
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
Published: January 22nd 2025 | Updated: January 22nd 2025The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.
Read More
